Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Minoru Sasano
Observed names:
M SASANO,
M Sasano,
M. Sasano,
MINORU SASANO,
Minoru SASANO
Institution:
AYUMI Pharmaceutical Corporation (Japan)
Observed institutions:
Santen (Japan),
Institut Pasteur,
Okayama University,
University of California San Diego,
Tokyo Metropolitan Ohtsuka Hospital,
Santen (United Kingdom),
Tokyo Women's Medical University,
AYUMI Pharmaceutical Corporation (Japan),
The University of Tokyo
show all 9
OpenAlex ID:
A5036701164
Augmented interleukin‐1 production and hla–dr expression in the synovium of rheumatoid arthritis patients
1988
·
Nobuyuki Miyasaka
, Kazuto Sato
, et al.
·
Arthritis & Rheumatism
·
217
Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture.
1987
·
M Goto
, M Sasano
, et al.
·
Journal of Clinical Investigation
·
111
PDF
Molecular selection of human antibodies with an unconventional bacterial B cell antigen.
1993
·
M Sasano
, D R Burton
, et al.
·
The Journal of Immunology
·
81
Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen.
1993
·
G J Silverman
, M Sasano
, et al.
·
The Journal of Immunology
·
66
Effects of combinations of anti‐rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis
2000
·
M. Nagashima
, K. Wauke
, et al.
·
Rheumatology
·
65
Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents
2009
·
Fumio Tsuji
, Masaaki Murai
, et al.
·
European Journal of Pharmacology
·
58
Superantigen properties of a human sialoprotein involved in gut-associated immunity.
1995
·
G J Silverman
, P Roben
, et al.
·
Journal of Clinical Investigation
·
54
PDF
Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition.
1990
·
M Goto
, M Fujisawa
, et al.
·
Annals of the Rheumatic Diseases
·
49
PDF
Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells
1999
·
M NAGASHIMA
, S YOSHINO
, et al.
·
Clinical & Experimental Immunology
·
44
DIFFERENTIAL EFFECTS BETWEEN MARIMASTAT, A TNF-α CONVERTING ENZYME INHIBITOR, AND ANTI-TNF-α ANTIBODY ON MURINE MODELS FOR SEPSIS AND ARTHRITIS
2002
·
Fumio Tsuji
, Kenji Oki
, et al.
·
Cytokine
·
33
SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-α production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo
2008
·
Masaaki Murai
, Fumio Tsuji
, et al.
·
European Journal of Pharmacology
·
31
Effects of SA13353, a Transient Receptor Potential Vanilloid 1 Agonist, on Leukocyte Infiltration in Lipopolysaccharide-Induced Acute Lung Injury and Ovalbumin-Induced Allergic Airway Inflammation
2010
·
Fumio Tsuji
, Masaaki Murai
, et al.
·
Journal of Pharmacological Sciences
·
24
PDF
Stimulation of interleukin‐1α and interleukin‐1β release from human monocytes by cyanogen bromide peptides of type ii collagen
1988
·
Makoto Goto
, Sadayoshi Yoshinoya
, et al.
·
Arthritis & Rheumatism
·
24
Constitutive production of angiotensin converting enzyme from rheumatoid nodule cells under serum free conditions.
1992
·
M Goto
, M Sasano
, et al.
·
Annals of the Rheumatic Diseases
·
21
PDF
ARG098, a novel anti-human Fas antibody, suppresses synovial hyperplasia and prevents cartilage destruction in a severe combined immunodeficient-HuRAg mouse model
2010
·
Noriko Odani-Kawabata
, Miwa Takai-Imamura
, et al.
·
BMC Musculoskeletal Disorders
·
17
PDF
Decrease in disease activity and concomitant increase in the percentage of peripheral blood suppressor T-cells in rheumatoid arthritis by a newly synthesized slow-acting anti-rheumatic drug (Bucillamine)
1989
·
Makoto Goto
, Minoru Sasano
, et al.
·
International Journal of Immunopharmacology
·
16
Bucillamine mechanism inhibiting IL-1β-induced VEGF production from fibroblast-like synoviocytes
2007
·
Fumio Tsuji
, Iwao Seki
, et al.
·
International Immunopharmacology
·
15
Salazosulfapyridine suppresses chondrocyte mediated degradation induced by interleukin 1beta.
1997
·
M Nose
, M Sasano
, et al.
·
PubMed
·
15
The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain
2011
·
Yaeko Tsukahara-Ohsumi
, Fumio Tsuji
, et al.
·
European Journal of Pharmacology
·
13
Effect of N-(2-carboxyphenyl)-4-chloroanthranilic Acid Disodium Salt (cca) on the Induction of Helper and Suppressor T Cells in Vitro and in Vivo
1983
·
Itaru YAMAMOTO
, Hitoshi OHMORI
, et al.
·
The Japanese Journal of Pharmacology
·
12
The Variable-Region Specificity of Bacterial Fab-Binding Proteins: The Search for B-Cell Superantigens
1993
·
Gregg J. Silverman
, Minoru Sasano
, et al.
·
ImmunoMethods
·
10
SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects
2010
·
Yaeko Tsukahara-Ohsumi
, Fumio Tsuji
, et al.
·
European Journal of Pharmacology
·
9
Suppressive effect of anti-rheumatic drugs on interleukin-1β release from human peripheral blood monocytes
1991
·
Masahiro Okamoto
, Minoru Sasano
, et al.
·
International Journal of Immunopharmacology
·
9
Adherent synovial cells from nonrheumatoid arthritis do not release interleukin 1 beta and prostaglandin E2 spontaneously in longterm culture.
1990
·
M Goto
, M Okamoto
, et al.
·
PubMed
·
9
The investigation of synovial genomic targets of bucillamine with microarray technique
2009
·
Kenji Oki
, Fumio Tsuji
, et al.
·
Inflammation Research
·
7
Show more works
View as search
Works count:
57
Citation count:
1,076
H-index:
16
I10-index:
21
Year
Topic
Type